Mounjaro and Zepbound helped drive the US drugmaker's total Q2 revenue to $15.56bn, up 38% from the same period last year. In a conference call, Eli Lilly CEO David Ricks acknowledged the role the ...
LONDON (Reuters) -In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims ...
Novo Nordisk filed 14 new lawsuits against compounders claiming to contain semaglutide, the component of its Ozempic and Wegovy meds.
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll ...
In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims & Hers.
Hims & Hers Health (HIMS) stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of Wall Street forecasts while maintaining its full-year forecast.
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll, releas… ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro which launched ...
Blockbuster diabetes and weight loss drugs from Eli Lilly and Novo Nordisk - including Mounjaro, Zepbound, Ozempic and Wegovy - generated over U$40 billion in combined sales last year. However ...
In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For ...
LONDON (Reuters) -In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims ...
Ozempic generated DKK 32.7 billion (up 15%), while Wegovy generated DKK 17.4 billion (up 83%) in sales in the first quarter of 2025. The combined figure accounted for around 66% of the company’s ...
But, in India, Mounjaro KwikPen has been approved by the Central Drugs Standard Control Organisation for six dose strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, the company was ...
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some ...
Novo Nordisk underestimated competition from compounded drugs when providing sales estimates for its GLP-1 treatments, says an investor lawsuit.
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
A new study reports that mice shed about 20% of their body weight and saw the size of their breast cancer tumors shrink after getting injected with tirzepatide, aka Mounjaro and Zepbound.
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some ...
Eli Lilly plans to move to a second Phase III trial for its oral GLP-1, while Novo Nordisk’s pill version of Wegovy also continues its path toward FDA approval.
Ozempic is hitting eating disorder centers hard About one in eight adults is taking a GLP-1, such as Ozempic and Mounjaro, designed for diabetes, and Zepbound and Wegovy, marketed for weight loss.